96 related articles for article (PubMed ID: 9772305)
21. Potentials and limitations of adenovirus-p53 gene therapy for brain tumors.
Hong YK; Joe YA; Yang YJ; Lee KS; Son BC; Jeun SS; Chung DS; Cho KK; Park CK; Kim MC; Kim HK; Yung WK; Kang JK
J Korean Med Sci; 2000 Jun; 15(3):315-22. PubMed ID: 10895975
[TBL] [Abstract][Full Text] [Related]
22. Effects of Gamma Knife surgery on C6 glioma in combination with adenoviral p53 in vitro and in vivo.
Xu D; Jia Q; Li Y; Kang C; Pu P
J Neurosurg; 2006 Dec; 105 Suppl():208-13. PubMed ID: 18503358
[TBL] [Abstract][Full Text] [Related]
23. Chimeric tumor suppressor 1, a p53-derived chimeric tumor suppressor gene, kills p53 mutant and p53 wild-type glioma cells in synergy with irradiation and CD95 ligand.
Naumann U; Kügler S; Wolburg H; Wick W; Rascher G; Schulz JB; Conseiller E; Bähr M; Weller M
Cancer Res; 2001 Aug; 61(15):5833-42. PubMed ID: 11479223
[TBL] [Abstract][Full Text] [Related]
24. Combination of fractionated irradiation with anti-VEGF expressing vaccinia virus therapy enhances tumor control by simultaneous radiosensitization of tumor associated endothelium.
Buckel L; Advani SJ; Frentzen A; Zhang Q; Yu YA; Chen NG; Ehrig K; Stritzker J; Mundt AJ; Szalay AA
Int J Cancer; 2013 Dec; 133(12):2989-99. PubMed ID: 23729266
[TBL] [Abstract][Full Text] [Related]
25. Intracerebral adenovirus-mediated p53 tumor suppressor gene therapy for experimental human glioma.
Li H; Alonso-Vanegas M; Colicos MA; Jung SS; Lochmuller H; Sadikot AF; Snipes GJ; Seth P; Karpati G; Nalbantoglu J
Clin Cancer Res; 1999 Mar; 5(3):637-42. PubMed ID: 10100717
[TBL] [Abstract][Full Text] [Related]
26. Microglia and astrocytes attenuate the replication of the oncolytic vaccinia virus LIVP 1.1.1 in murine GL261 gliomas by acting as vaccinia virus traps.
Kober C; Rohn S; Weibel S; Geissinger U; Chen NG; Szalay AA
J Transl Med; 2015 Jul; 13():216. PubMed ID: 26149494
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of pGL1-TNF-alpha therapy in combination with radiation.
Li J; Andres ML; Fodor I; Nelson GA; Gridley DS
Oncol Res; 1998; 10(7):379-87. PubMed ID: 10063972
[TBL] [Abstract][Full Text] [Related]
28. TNF-alpha gene and proton radiotherapy in an orthotopic brain tumor model.
Gridley DS; Baer JR; Cao JD; Miller GM; Kim DW; Timiryasova TM; Fodor I; Slater JM
Int J Oncol; 2002 Aug; 21(2):251-9. PubMed ID: 12118318
[TBL] [Abstract][Full Text] [Related]
29. Attenuation of a vaccine strain of vaccinia virus via inactivation of interferon viroceptor.
Dénes B; Gridley DS; Fodor N; Takátsy Z; Timiryasova TM; Fodor I
J Gene Med; 2006 Jul; 8(7):814-23. PubMed ID: 16634110
[TBL] [Abstract][Full Text] [Related]
30. Synergistic inhibition of human lung cancer cell growth by adenovirus-mediated wild-type p53 gene transfer in combination with docetaxel and radiation therapeutics in vitro and in vivo.
Nishizaki M; Meyn RE; Levy LB; Atkinson EN; White RA; Roth JA; Ji L
Clin Cancer Res; 2001 Sep; 7(9):2887-97. PubMed ID: 11555607
[TBL] [Abstract][Full Text] [Related]
31. Therapeutic efficacy of PUMA for malignant glioma cells regardless of p53 status.
Ito H; Kanzawa T; Miyoshi T; Hirohata S; Kyo S; Iwamaru A; Aoki H; Kondo Y; Kondo S
Hum Gene Ther; 2005 Jun; 16(6):685-98. PubMed ID: 15960600
[TBL] [Abstract][Full Text] [Related]
32. Enhancement of radiosensitivity of wild-type p53 human glioma cells by adenovirus-mediated delivery of the p53 gene.
Lang FF; Yung WK; Raju U; Libunao F; Terry NH; Tofilon PJ
J Neurosurg; 1998 Jul; 89(1):125-32. PubMed ID: 9647183
[TBL] [Abstract][Full Text] [Related]
33. Interferon gamma is involved in the recovery of athymic nude mice from recombinant vaccinia virus/interleukin 2 infection.
Karupiah G; Blanden RV; Ramshaw IA
J Exp Med; 1990 Nov; 172(5):1495-503. PubMed ID: 2121889
[TBL] [Abstract][Full Text] [Related]
34. Combined effects of radiotherapy and angiostatin gene therapy in glioma tumor model.
Griscelli F; Li H; Cheong C; Opolon P; Bennaceur-Griscelli A; Vassal G; Soria J; Soria C; Lu H; Perricaudet M; Yeh P
Proc Natl Acad Sci U S A; 2000 Jun; 97(12):6698-703. PubMed ID: 10823901
[TBL] [Abstract][Full Text] [Related]
35. Combined antitumor effects of an adenoviral cytosine deaminase/thymidine kinase fusion gene in rat C6 glioma.
Chang JW; Lee H; Kim E; Lee Y; Chung SS; Kim JH
Neurosurgery; 2000 Oct; 47(4):931-8; discussion 938-9. PubMed ID: 11014433
[TBL] [Abstract][Full Text] [Related]
36. Immunogenicity and safety of defective vaccinia virus lister: comparison with modified vaccinia virus Ankara.
Ober BT; Brühl P; Schmidt M; Wieser V; Gritschenberger W; Coulibaly S; Savidis-Dacho H; Gerencer M; Falkner FG
J Virol; 2002 Aug; 76(15):7713-23. PubMed ID: 12097585
[TBL] [Abstract][Full Text] [Related]
37. Vaccinia as a vector for tumor-directed gene therapy: biodistribution of a thymidine kinase-deleted mutant.
Puhlmann M; Brown CK; Gnant M; Huang J; Libutti SK; Alexander HR; Bartlett DL
Cancer Gene Ther; 2000 Jan; 7(1):66-73. PubMed ID: 10678358
[TBL] [Abstract][Full Text] [Related]
38. Liposome-encapsulated tumor necrosis factor-alpha enhances the effects of radiation against human colon tumor xenografts.
Kim DW; Andres ML; Li J; Kajioka EH; Miller GM; Seynhaeve AL; Ten Hagen TL; Gridley DS
J Interferon Cytokine Res; 2001 Nov; 21(11):885-97. PubMed ID: 11747620
[TBL] [Abstract][Full Text] [Related]
39. Enhanced radiosensitivity of malignant glioma cells after adenoviral p53 transduction.
Broaddus WC; Liu Y; Steele LL; Gillies GT; Lin PS; Loudon WG; Valerie K; Schmidt-Ullrich RK; Fillmore HL
J Neurosurg; 1999 Dec; 91(6):997-1004. PubMed ID: 10584846
[TBL] [Abstract][Full Text] [Related]
40. Combination therapy of malignant glioma cells with 2-5A-antisense telomerase RNA and recombinant adenovirus p53.
Komata T; Kondo Y; Koga S; Ko SC; Chung LW; Kondo S
Gene Ther; 2000 Dec; 7(24):2071-9. PubMed ID: 11223987
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
